【迈威生物：9MW2821治疗宫颈癌III期临床研究获CDE同意】金十数据8月22日讯，迈威生物公告，公司自主研发的创新药9MW2821获得国家药品监督管理局药品审评中心同意，针对含铂化疗失败的复发或转移性宫颈癌进行III期临床研究。

美港电讯08-22 17:21

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2461398185?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2024-08-22 17:21","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2461398185","market":"hk","top_or_hot":-1,"title":"【迈威生物：9MW2821治疗宫颈癌III期临床研究获CDE同意】金十数据8月22日讯，迈威生物公告，公司自主研发的创新药9MW2821获得国家药品监督管理局药品审评中心同意，针对含铂化疗失败的复发或转移性宫颈癌进行III期临床研究。","media":"美港电讯","content":"<html><body><p>【迈威生物：9MW2821治疗宫颈癌III期临床研究获CDE同意】金十数据8月22日讯，迈威生物公告，公司自主研发的创新药9MW2821获得国家药品监督管理局药品审评中心同意，针对含铂化疗失败的复发或转移性宫颈癌进行III期临床研究。</p></body></html>","source":"live_meigang","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>7x24快讯</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n7x24快讯\n</h2>\n\n<h4 class=\"meta\">\n\n<p class=\"head\">\n<strong class=\"h-name small\">美港电讯</strong><span class=\"h-time small\">2024-08-22 17:21</span>\n</p>\n\n</h4>\n\n</header>\n<article>\n<html><body><p>【迈威生物：9MW2821治疗宫颈癌III期临床研究获CDE同意】金十数据8月22日讯，迈威生物公告，公司自主研发的创新药9MW2821获得国家药品监督管理局药品审评中心同意，针对含铂化疗失败的复发或转移性宫颈癌进行III期临床研究。</p></body></html>\n\n<div class=\"bt-text\">\n\n\n<p> 来源：<a href=\"https://www.ushknews.com/\">美港电讯</a> </p>\n\n<p>为提升您的阅读体验，我们对本页面进行了排版优化</p>\n\n</div>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4134","symbol_name":"信息科技咨询与其它服务","start_time":0,"source_url":"https://www.ushknews.com/","article_id":"2461398185","we_media_id":null,"thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2461398185","pubTimestamp":1724318470,"sourceInfo":{"source_id":"live_meigang","name":"美港电讯"},"weMediaInfo":null,"summary":"【迈威生物：9MW2821治疗宫颈癌III期临床研究获CDE同意】金十数据8月22日讯，迈威生物公告，公司自主研发的创新药9MW2821获得国家药品监督管理局药品审评中心同意，针对含铂化疗失败的复发或","collect":0,"end_time":0,"defaultTopTitle":"ushknews.com","property":[],"viewcount":null,"language":"zh","relate_stocks":{"159992":"创新药","688062":"迈威生物","BK4134":"信息科技咨询与其它服务","06978":"永泰生物-B","III":"信息服务","BK0239":"医药制造","BK4017":"黄金","BK1161":"生物科技","BK1574":"生物医药B类股","CDE":"科尔黛伦矿业"},"translate_title":"[Maiwei Bio: Phase III clinical study of 9MW2821 in the treatment of cervical cancer was approved by CDE] Jinshi Data August 22, Maiwei Bio announced that the company's independently developed innovative drug 9MW2821 was approved by the Drug Evaluation Center of the State Medical Products Administration. Phase III clinical study of recurrent or metastatic cervical cancer that has failed platinum-containing chemotherapy.","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"159992":1,"688062":1,"06978":1,"CDE":1,"III":1},"content_text":"【迈威生物：9MW2821治疗宫颈癌III期临床研究获CDE同意】金十数据8月22日讯，迈威生物公告，公司自主研发的创新药9MW2821获得国家药品监督管理局药品审评中心同意，针对含铂化疗失败的复发或转移性宫颈癌进行III期临床研究。","kind":null,"is_publish_news":false,"is_publish_highlight":false,"is_publish_live":true,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":0},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.26.2","shortVersion":"4.26.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2461398185"}